Genomic profiles of BRAF inhibitor resistance mechanisms in metastatic colorectal cancer.
Ting Xu(The University of Texas MD Anderson Cancer Center), Xi Li(Central South University), Lu Zhang(Burning Rock Biotech (China)), Jian Li(Beijing Normal University), Xicheng Wang(Shandong University of Traditional Chinese Medicine), Lin Shen(Peking University), Xuan Lin(Beijing Technology and Business University), QI Chang-song(Peking University), Jing Lin(First Affiliated Hospital of Chinese PLA General Hospital), Jia Wang(Shantou University), Zhenghang Wang(Peking University)
Cited by 5
Related Papers
Complete Revascularization with Multivessel PCI for Myocardial Infarction
|New England Journal of Medicine|2019|926
The genesis and source of the H7N9 influenza viruses causing human infections in China
|Nature|2013|479
Circulating tumor DNA dynamics predict benefit from consolidation immunotherapy in locally advanced non-small-cell lung cancer
|Nature Cancer|2020|369
Advances and perspectives in organic sonosensitizers for sonodynamic therapy
|Coordination Chemistry Reviews|2021|323
The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease
|Lipids in Health and Disease|2017|298